The document discusses the anatomy, physiology, diagnosis and treatment of peptic ulcers. It provides details on:
- The cells that line the stomach and secrete substances like mucus, hydrochloric acid and gastrin.
- How gastrin stimulates acid secretion through histamine release from ECL cells. Tests used to diagnose ulcers include endoscopy, histology, urea breath test and stool antigen tests.
- Helicobacter pylori infection is a major cause of ulcers through damaging the mucosal defense barrier. Treatment involves eradicating H. pylori with antibiotic combinations and reducing acid with proton pump inhibitors.
This ppt is suitable for b.pharma students. This ppt is prepared according to b.pharma IInd semester syallbus. In this ppt we provide all topics related to pathophysiology of peptic ulcer. In this ppt we covered introduction, types, sign & symptoms, pathophysiology, diagnosis, complications and treatments.
CHRONIC DYSPEPSIA
Seminar Prepared by :-
Ali Abdulazeem
Shilan Adnan Abdulrahman
Alaa Shamil
Guldan Hameed
Internal Medicine
College of Medicine - University of Kirkuk
This ppt is suitable for b.pharma students. This ppt is prepared according to b.pharma IInd semester syallbus. In this ppt we provide all topics related to pathophysiology of peptic ulcer. In this ppt we covered introduction, types, sign & symptoms, pathophysiology, diagnosis, complications and treatments.
CHRONIC DYSPEPSIA
Seminar Prepared by :-
Ali Abdulazeem
Shilan Adnan Abdulrahman
Alaa Shamil
Guldan Hameed
Internal Medicine
College of Medicine - University of Kirkuk
A localized loss of gastric as well as duodenal mucosa leads to the formation of peptic ulcer.
A peptic ulcer is a sore on the lining of your stomach, small intestine or esophagus. A peptic ulcer in the stomach is called a gastric ulcer. A duodenal ulcer is a peptic ulcer that develops in the first part of the small intestine (duodenum). An esophageal ulcer occurs in the lower part of your esophagus.
Peptic ulcer arises when the normal mucosal defense mechanisms (mucus blood flow formation of HCO3- PGE2 ) are impaired or overpowered by damaging factors (acids pepsin pylori)
Ulcers occur 5 times more commonly in the duodenum and 95% of them are found in pyloric channel
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
5. • Mucous cells in the gastric
pits secrete mucus
• parietal cells secrete
hydrochloric acid
• G cells, which are present
predominantly only in the
antrum of the stomach,
secrete gastrin
• ECL cells secrete histamine
• chief cells secrete
pepsinogen
6.
7.
8. Control of acid secretion.
Gastrin released from antral G cells
in response to food binds to
cholecystokinin receptors (CCK-
2R) on the surface of
enterochromaffin-like (ECL) cells,
which in turn release histamine.
The histamine binds to H2
receptors on parietal cells and
this leads to secretion of
hydrogen ions, in exchange for
potassium ions at the apical
membrane. Parietal cells also
express CCK-2R and it is thought
that activation of these
receptors by gastrin is involved
in regulatory proliferation of
parietal cells. Cholinergic (vagal)
activity and gastric distension
also stimulate acid secretion;
somatostatin, vasoactive
intestinal polypeptide (VIP) and
gastric inhibitory polypeptide
(GIP) inhibit it.
21. Etiology of PUD
• Normal
• Increased Attack
Hyperacidity
• Weak defense
Helicobacter pylori*
Stress, drugs, smoking
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33. A gastric ulcer caused by
H.pylori
A duodenal ulcer caused by
H.pylori
34. Risk factors
Older than 60 years of age
Previous peptic ulcer
Previous ulcer-related upper GI
complication
Concomitant use of corticosteroid
High-dose NSAIDs
Multiple NSAID use or NSAID plus
aspirin use
Aspirin (including
cardioprotective dosages)
Concomitant use of anticoagulant
Concomitant use of antiplatelet
drug such as clopidogrel
Concomitant use of selective
serotonin reuptake inhibitor
Chronic illness (e.g.,
cardiovascular disease)
NSAID-related dyspepsia
Helicobacter pylori infection
Rheumatoid arthritis (extent of
disability)
Alcohol consumption
Cigarette smoking
35. Symptoms
The most common symptom of peptic ulcers is abdominal pain.
The pain is usually in the upper middle part of the abdomen,
above the belly button and below the breastbone.
The pain can feel like burning or gnawing, and it may go through
to the back.
Pain often comes several hours after a meal when the stomach is
empty.
The pain is often worse at night and early morning.
It can last anywhere from a few minutes to several hours.
The pain may be relieved by food, antacids, or vomiting.
36. Other symptoms of peptic ulcers include the following:
Nausea
Vomiting
Loss of appetite
Loss of weight
Severe ulcers may cause bleeding in the stomach or duodenum. Bleeding is
sometimes the only symptom of an ulcer. This bleeding can be fast or slow.
Fast bleeding reveals itself in one of the following ways:
Vomiting of blood or dark material that looks something like coffee grounds: This is
an emergency and warrants an immediate visit to an emergency department.
Blood in the stool or black, tarry, sticky-looking stools
Slow bleeding is often more difficult to detect, because it has no dramatic symptoms.
The usual result is low blood cell count.
The symptoms of anemia are tiredness (fatigue), lack of energy (lethargy),
weakness, rapid heartbeat (tachycardia), and pales skin (pallor).
37. Pathogenesis
A physiologic imbalance between aggressive factors (gastric acid and pepsin) and
protective factors (mucosal defense and repair) remain important issues in the
pathophysiology of gastric and duodenal ulcers
38. THANKYOU
Gram negative, Spiral bacilli
Spirochetes
Do not invade cells – only mucous
Breakdown urea - ammonia
Break down mucosal defense
Chronic Superficial inflammation
43. PUD - Diagnosis
Endoscopic tests
Histology
Microbiologic examination using various stains
Culture of biopsy
Biopsy (rapid) urease
HP urease generates ammonia, which causes a color change
Nonendoscopic tests
Antibody detection(laboratory-based)
Detects antibodies to HP in serum; in the U.S., only FDA-approved anti-HP lgG
antibody should be Used
Antibody detection (can be performed in office or near patient)
Detects lgG antibodies to HP in whole blood or finger stick
Urea breath test (UBT)
HP urease breaks down ingested labeled C-urea, patient exhales labeled CO2
Stool antigen Identifies
HP antigen in stool, leading to color change that can be detected visually or by
spectrophotometer
Barium meal – contrast x-ray
ELISA
51. Urease test
T he Endosc-Hp® Test consists
of a twin well cartridge
containing urea, phenol red
and buffer salts when
reconstituted, and a buffer. If
the urease enzyme of
Helicobacter pylori is present
in a biopsy specimen, the rise
in pH associated with the
hydrolysis of urea causes a
change in colour from yellow to
pink/red. The colour change
indicates a positive reaction
and confirms the presence of
Helicobacter pylori. (30minute)
Urease is a constitutively expressed enzyme that
hydrolyzes urea to carbon dioxide and ammonia.
(NH2)2CO + H2O → CO2 + 2NH3
Urease test media contain 2% urea and phenol red as a
pH indicator. An increase in pH due to the production of
ammonia results in a color change from yellow (pH 6.8)
to bright pink (pH 8.2).
52. Rapid test for H.Pylori
CLIAwaived H. pylori Whole Blood
Rapid Test. A rapid qualitative
immunoassay intended to detect
the presence of IgG antibodies
specific to Helicobacter pylori (H.
pylori) in human whole blood.
54. Indirect ELISA
A sandwich ELISA. (1) Plate is coated with a
capture antibody; (2) sample is added, and any
antigen present binds to capture antibody; (3)
detecting antibody is added, and binds to
antigen; (4) enzyme-linked secondary antibody
is added, and binds to detecting antibody; (5)
substrate is added, and is converted by enzyme
to detectable form.
56. TREATMENT OF PUD
• The treatment selected for PUD depends on
the following factors:
(1)the etiology of the ulcer
(2)whether the ulcer is new or recurrent
(3)the presence of any ulcer-related
complications.
• Overall treatment is aimed-
relieving ulcer pain
healing the ulcer
preventing ulcer recurrence
and reducing ulcer-related complications.
57. The goals of PUD therapy are to--
(1) resolve symptoms
(2) reduce acid secretion
(3) promote epithelial healing
(4) prevent ulcer-related complications
(5) Prevent ulcer recurrence.
(6) For HP-related PUD, eradication of HP is
an additional goal
58. NONPHARMACOLOGIC THERAPY
• Patients with PUD should eliminate or
reduce psychological stress, cigarette
smoking, and the use of nonselective
NSAIDs (including aspirin).
• Although there is no “antiulcer diet,” the
patient should avoid foods and beverages
(e.g., spicy foods, caffeine, and alcohol)
that cause dyspepsia or that exacerbate
ulcer symptoms.
• If possible, alternative agents such as
acetaminophen, nonacetylated salicylate
60. PYLOROPLASTY
This surgery enlarges the opening through which
stomach contents are emptied into the intestine, allowing
the stomach to empty more quickly.
61. ANTRECTOMY
Remove the lower part of the stomach (antrum), which
produces a hormone that stimulates the stomach to
secrete digestive juices. A vagotomy is usually done in
conjunction with an antrectomy.
67. Guidelines for the evaluation and management of a
patient who presents with dyspeptic or ulcer-like
symptoms. COX-2, cyclooxygenase-2; GERD,
gastroesophageal reflux disease; HP,Helicobacter
pylori; H2-RA, H2-receptor antagonist; PPI, proton
pump inhibitor; NSAID, nonsteroidal anti-inflammatory
drug; NUD, nonulcer dyspepsia.
71. Proton pump inhibitor
Omeprazole is inactive at neutral pH, but at pH < 5
rearranges to two charged cationic forms (a sulphenic acid
and a sulphenamide configurations) that react covalently
with SH groups of the H+/K+ATPase enzyme and inactivate it
irreversibly, especially when two molecules of omeprazole
react with one molecule of the enzyme. After diffusing into
the parietal cell from blood, it gets concentrated in the
acidic pH of the canaliculi because the charged forms
generated there are unable to diffuse back.
72.
73. Sucralfate (CARAFATE) consists of the octasulfate of
sucrose to which Al(OH)3 has been added. In an acid
environment (pH <4), sucralfate undergoes extensive
cross-linking to produce a viscous, sticky polymer that
adheres to epithelial cells and ulcer craters for up to 6
hours after a single dose.Colloidal bismuth compound
(i) Increased secretion of mucus and bicarbonate through
stimulation of mucosal PGE2 production.
(ii) CBS and mucus form a glycoprotein-Bi complex which
coats the ulcer and acts as a diffusion barrier to HCl.
(iii) Detaches H pylori from the surface of mucosa and
directiy kills this organism involved in causation of ulcers
and relapses.
74. Treatment and dosing recommendations to heal peptic ulcers
or provide maintenance therapy are shown here---
75. Treatment of Helicobacter pylori–Associated Ulcers
The primary goal of HP therapy is to completely
eradicate the organism using an effective antibiotic-
containing regimen.
Eradication therapy with a PPI-based three-drug regimen
should be considered for all patients who test positive for
HP and have an active ulcer or a documented history of
either an ulcer or ulcer-related complication. Different
antibiotics should be used if a second course of HP
eradication therapy is required.
The first-line regimen should contain a PPI plus
clarithromycin and either amoxicillin or metronidazole.
77. Treatment of NSAID-Induced Ulcers
For patients discontinuing NSAID therapy, PPIs,
H2RAs, or sucralfate are all effective for ulcer
healing.
PPI therapy heals NSAID ulcers faster than
H2RAs.
For patients continuing NSAID therapy, PPIs are
preferred over H2RAs or sucralfate.
If the decision is made to continue NSAID
therapy, adjunctive strategies may be required to
78. Prevention of NSAID-Induced Ulcers
Prophylactic regimens against PUD are often required in
patients who require long-term NSAID or aspirin therapy
for osteoarthritis, rheumatoid arthritis, or cardioprotection.
Misoprostol, H2RAs, PPIs, and COX-2 selective inhibitors
have been evaluated in controlled trials to reduce the risk
of NSAID-induced PUD.Treatment of Refractory Ulcers
The presence of refractory ulcers [ulcers that persist
beyond 8 weeks (DU) or 12 weeks (GU)] requires thorough
assessment, including evaluation of medication
compliance.
The patient should be questioned regarding recent
NSAID ingestion.
Tolerance has been reported with as few as 4 weeks of
H2RA therapy, and thus a change to PPI therapy should be
considered in this situation.
Other assessments that may be considered include an
79. Patient Care and Monitoring
General Recommendations: HP-Associated and NSAID Induced Ulcers
1. Assess the severity of signs and symptoms. Identify the
presence of any alarm signs and symptoms.
2. Educate the patient on monitoring for alarm signs and
symptoms.
3. Obtain a history of prescription medication, over-the counter
medication, and dietary supplement use.
4. Encourage lifestyle modifications such as reducing tobacco
use and ethanol ingestion and decreasing psychological stress.
5. Determine the appropriate duration of therapy for acid
suppressive therapy.
6. Define the current impact of PUD on the patient’s quality of life
and the improvement in these outcomes sought with drug
therapy.
7. Evaluate current drug therapy for potential adverse drug
reactions and drug interactions.
Helicobacter pylori–Associated Ulcers
1. Recommend an appropriate drug regimen that will eradicate
80. 4. Recommend different antibiotics if this treatment
regimen is a result of failure of a prior HP regimen.
5. Educate the patient on the importance of adherence to
eradication therapy.
NSAID-Associated Ulcers
1. Assess for risk factors for NSAID ulcers and recommend
an appropriate strategy to reduce ulcer risk.
2. Monitor for signs and symptoms of complications
associated with NSAID-related ulceration.
3. Recommend an appropriate treatment regimen to
achieve the desired outcomes.
4. Assess and counsel patients on potential adverse drug
events and drug interactions.
5. Inform patients who are receiving prophylactic therapy
on the importance of its use, potential adverse drug
events, and the possible alarm symptoms associated with
Editor's Notes
Physiological and pharmacological regulation of gastric secretion: the basis for therapy of acid-peptic disorders. Shown are the interactions among an enterochromaffin-like (ECL) cell that secretes histamine, a parietal cell that secretes acid, and a superficial epithelial cell that secretes cytoprotective mucus and bicarbonate. Physiological pathways, shown in solid black, may be stimulatory (+) or inhibitory (-). 1 and 3 indicate possible inputs from postganglionic cholinergic fibers, while 2 shows neural input from the vagus nerve. Physiological agonists and their respective membrane receptors include: acetylcholine (ACh), muscarinic (M), and nicotinic (N) receptors; gastrin, cholecystokinin receptor 2 (CCK2); histamine (HIST), H2 receptor; and prostaglandin E2 (PGE2), EP3 receptor. Drug actions are indicated by dashed lines. A blue X indicates targets of pharmacological antagonism. A light blue dashed arrow indicates a drug action that mimics or enhances a physiological pathway. Shown in blue are drugs used to treat acid-peptic disorders. NSAIDs are nonsteroidal antiinflammatory drugs and are ulcerogenic. Prostaglandin E receptor 3, also known as EP3, is a prostaglandin receptor, encoded by the PTGER3 gene.[1] The receptor is a member of the G-protein coupled receptor family. It works through the G protein Gi, leading to a decrease in cytosolic cyclic AMP (cAMP). It is one of four receptors identified for prostaglandin E2 (PGE2). This receptor may have many biological functions, which involve digestion, nervous system, kidney reabsorption, and uterine contraction activities. In the stomach, it inhibits gastric acid secretions.
H.Pylori Immunoassay testing device is based on the double antigens sandwich immunoassay principle. When testing with a helicobacter pylori test cassette, H.pylori antigen–colloid gold conjugate and serum sample move along the membrane chromatographically to the test line region (T), where H.pylori capturing antigen is pre-coated. If antibodies to H.Pylori exist in the specimen, "antigen-antibody-antigen" gold particle complex will form, a pink color band will appear on the test region. If the inside quality control line (C) also emerge, then the two pink lines give a positive result. And on the contrary, if there is no antibody to the H.Pylori bacterium in the serum specimen, the "antigen-antibody-antigen" gold particle complex will not form at the test region, indicating a negative result.
Guidelines for the evaluation and management of a patient who presents with dyspeptic or ulcer-like symptoms. COX-2, cyclooxygenase-2; GERD, gastroesophageal reflux disease; HP,Helicobacter pylori; H2-RA, H2-receptor antagonist; PPI, proton pump inhibitor; NSAID, nonsteroidal anti-inflammatory drug; NUD, nonulcer dyspepsia.
Physiological and pharmacological regulation of gastric secretion: the basis for therapy of acid-peptic disorders. Shown are the interactions among an enterochromaffin-like (ECL) cell that secretes histamine, a parietal cell that secretes acid, and a superficial epithelial cell that secretes cytoprotective mucus and bicarbonate. Physiological pathways, shown in solid black, may be stimulatory (+) or inhibitory (-). 1 and 3 indicate possible inputs from postganglionic cholinergic fibers, while 2 shows neural input from the vagus nerve. Physiological agonists and their respective membrane receptors include: acetylcholine (ACh), muscarinic (M), and nicotinic (N) receptors; gastrin, cholecystokinin receptor 2 (CCK2); histamine (HIST), H2 receptor; and prostaglandin E2 (PGE2), EP3 receptor. Drug actions are indicated by dashed lines. A blue X indicates targets of pharmacological antagonism. A light blue dashed arrow indicates a drug action that mimics or enhances a physiological pathway. Shown in blue are drugs used to treat acid-peptic disorders. NSAIDs are nonsteroidal antiinflammatory drugs and are ulcerogenic. Prostaglandin E receptor 3, also known as EP3, is a prostaglandin receptor, encoded by the PTGER3 gene.[1] The receptor is a member of the G-protein coupled receptor family. It works through the G protein Gi, leading to a decrease in cytosolic cyclic AMP (cAMP). It is one of four receptors identified for prostaglandin E2 (PGE2). This receptor may have many biological functions, which involve digestion, nervous system, kidney reabsorption, and uterine contraction activities. In the stomach, it inhibits gastric acid secretions.
aThese regimens based on efficacy for a 14-day treatment duration unless otherwise noted.
bCure rates based on intention-to-treat analysis from references 3, 12, 14, and 35, where: poor = less than 70% eradication, fair =
70–80%, good = 80–90%, and excellent = greater than 90%.
cH2RA therapy should be continued for an additional 2 weeks.
dDuration of therapy is 7–10 days.
eData based on refractory treatment data.
fGiven for 7 days.
gGiven for 10 days.
BSS, bismuth subsalicylate; H2RA, H2-receptor antagonist; PPI, proton pump inhibitor; RBC, ranitidine bismuth citrate (not available
in the United States).